Delivery Order SPE2DB22D1017-SPE2DB25FE7WP

Award Date 10/25/24
Potential Completion Date 10/28/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at up to $1,952.97, is a delivery order for the supply of Amlodipine-Valsartan 10-320 mg medication in 30-count packages. This award is not a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,194.39, is for the delivery of AMLODIPINE-VALSARTAN 10-160 MG 30S tablets. It is a firm fixed-price delivery order contract with an ultimate completion date of April 8, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,437.87, is for the delivery of Amlodipine-Valsartan 10-320 mg tablets. This is a firm fixed-price delivery order contract with a completion date of February 13, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite...
This federal contract award, with the ID SPE2DB22D3016|SPE2DB24FAVU7, was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp's Corporate Office Division. The $2,538.76 firm fixed-price delivery order is for the supply of Amlodipine-Valsartan 5-160 mg tablets, with a completion date of May 16, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,580.84 firm fixed-price delivery order covers the provision of Valsartan-HCTZ 160-25 mg tablets for a period ending on December 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,792.95 Firm Fixed Price delivery order is for the supply of Telmisartan-Amlodipine 40-5 mg tablets. The contract has an ultimate completion date of November 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,161.72, is for the delivery of AMLODIPINE-VALSARTAN 10-160 MG 30S, a cardiovascular medication. This is a delivery order contract with a firm fixed price pricing type, with a completion date of March 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,063.12 firm fixed-price delivery order is for the supply of Valsartan-HCTZ 320-25 mg tablets. The award is not designated as a set-aside and represents an individual delivery order under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is a delivery order issued under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,612.54, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,563,226,563 Valsartan-HCTZ 320-25 mg tablets in 90-count packages, with an ultimate completion date of January 4, 2024. The contract does not have a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of VALSARTAN-HCTZ 160-12.5 MG TAB 90S. The $8,953.53 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 25, 2024. The contract is not designated with a set-aside requirement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FE7WP
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide Amlodipine-Valsartan 10-320 mg tablets. The $1,932.88 firm fixed-price delivery order has an ultimate completion date of October 28, 2024. It is not associated with any set-aside requirements.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for supplying a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable streamlined federal procurement of essential drugs and medical items for military personnel, veterans, and other government beneficiaries.

Generated 1/24/25, 9:26 AM